[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Wang et al., 2022 - Google Patents

Progress of electrospun nanofibrous carriers for modifications to drug release profiles

Wang et al., 2022

View HTML
Document ID
315448054453047859
Author
Wang Y
Yu D
Liu Y
Liu Y
Publication year
Publication venue
Journal of Functional Biomaterials

External Links

Snippet

Electrospinning is an advanced technology for the preparation of drug-carrying nanofibers that has demonstrated great advantages in the biomedical field. Electrospun nanofiber membranes are widely used in the field of drug administration due to their advantages such …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30—Macromolecular compounds
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Similar Documents

Publication Publication Date Title
Wang et al. Progress of electrospun nanofibrous carriers for modifications to drug release profiles
Shahriar et al. Electrospinning nanofibers for therapeutics delivery
Zhang et al. Polymer-based nanofiber–nanoparticle hybrids and their medical applications
Pant et al. Drug delivery applications of core-sheath nanofibers prepared by coaxial electrospinning: A review
Contreras-Cáceres et al. Electrospun nanofibers: Recent applications in drug delivery and cancer therapy
Liu et al. Electrospun medicated nanofibers for wound healing
Singh et al. On-demand drug delivery systems using nanofibers
Chyzy et al. Hydrogels as potential nano-, micro-and macro-scale systems for controlled drug delivery
Wang et al. Tri-layer core–shell fibers from coaxial electrospinning for a modified release of metronidazole
Zhang et al. Alginate-based electrospun nanofibers and the enabled drug controlled release profiles: a review
Xu et al. The effect of drug heterogeneous distributions within core-sheath nanostructures on its sustained release profiles
Li et al. Drug delivery applications of coaxial electrospun nanofibres in cancer therapy
Gizaw et al. Electrospun fibers as a dressing material for drug and biological agent delivery in wound healing applications
Jiffrin et al. Electrospun nanofiber composites for drug delivery: a review on current progresses
Arun et al. Collagen nanoparticles in drug delivery systems and tissue engineering
El-Ghoul et al. Recent advances in functional polymer materials for energy, water, and biomedical applications: a review
Ji et al. Electrosprayed stearic-acid-coated ethylcellulose microparticles for an improved sustained release of anticancer drug
Sosnik et al. Polymeric hydrogels as technology platform for drug delivery applications
Ji et al. A review on electrospun poly (amino acid) nanofibers and their applications of hemostasis and wound healing
Yu et al. Hyaluronic acid coated acid-sensitive nanoparticles for targeted therapy of adjuvant-induced arthritis in rats
Liu et al. Hybrid films prepared from a combination of electrospinning and casting for offering a dual-phase drug release
Miranda et al. Tunable spun fiber constructs in biomedicine: Influence of processing parameters in the fibers’ architecture
Wani et al. Silk fibroin as an efficient biomaterial for drug delivery, gene therapy, and wound healing
Xu et al. Electrosprayed core (cellulose acetate)–shell (polyvinylpyrrolidone) nanoparticles for smart acetaminophen delivery
Constantino et al. Biomaterials based on organic polymers and layered double hydroxides nanocomposites: Drug delivery and tissue engineering